Call planned today at 8:30 a.m. (ET) to discuss company's diabetes program progression The INHALE-1 study is a 26-week, ...

MILLIONS have been urged to protect themselves a “tidal wave” of flu and winter bugs in the days before Christmas. Eligible ...

3. Experts Explore Barriers to Diversity in Respiratory Medicine ... for COPD Two abstracts presented at ATS 2024 ...

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I’m dealing with the effects of it ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.

Inhalers and nebulizers play a key role in delivering medication to the lungs, making it easier for people with breathing ...

Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and ...